262 related articles for article (PubMed ID: 24703101)
21. The Value of BRAF VE1 Immunoexpression in Pediatric Langerhans Cell Histiocytosis.
Phan DAT; Phung GB; Duong TT; Hoang AV; Ngo QD; Trinh DTN; Tran TT
Fetal Pediatr Pathol; 2022 Aug; 41(4):558-567. PubMed ID: 33295826
[No Abstract] [Full Text] [Related]
22.
El Sissy FN; Lorillon G; Mandonnet E; Polivka M; Addle-Biassette H; Emile JF
Clin Neuropathol; 2020; 39(2):64-69. PubMed ID: 31661070
[TBL] [Abstract][Full Text] [Related]
23.
Ozer E; Sevinc A; Ince D; Yuzuguldu R; Olgun N
Pediatr Dev Pathol; 2019 Oct; 22(5):449-455. PubMed ID: 31072207
[TBL] [Abstract][Full Text] [Related]
24. Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis.
Chilosi M; Facchetti F; Caliò A; Zamò A; Brunelli M; Martignoni G; Rossi A; Montagna L; Piccoli P; Dubini A; Tironi A; Tomassetti S; Poletti V; Doglioni C
Leuk Lymphoma; 2014 Nov; 55(11):2620-6. PubMed ID: 24471909
[TBL] [Abstract][Full Text] [Related]
25. [Combined histiocytosis of the Langerhans group (Langerhans cell histiocytosis and Erdheim-Chester disease) in a 64-year-old man with BRAF and NRAS mutations: a case report].
Rodríguez-Duque MS; Martín Soler P; González Vela MC; Gómez Román JJ
Rev Esp Patol; 2023; 56(3):186-190. PubMed ID: 37419557
[TBL] [Abstract][Full Text] [Related]
26. Langerhans cell histiocytosis: A neoplastic disorder driven by Ras-ERK pathway mutations.
Tran G; Huynh TN; Paller AS
J Am Acad Dermatol; 2018 Mar; 78(3):579-590.e4. PubMed ID: 29107340
[TBL] [Abstract][Full Text] [Related]
27. High Prevalence of
Liu X; Zhang Y; Zhou CX
Int J Surg Pathol; 2019 Dec; 27(8):836-843. PubMed ID: 31203679
[TBL] [Abstract][Full Text] [Related]
28. BRAF gene mutations in synchronous papillary thyroid carcinoma and Langerhans cell histiocytosis co-existing in the thyroid gland: a case report and literature review.
A Al Hamad M; Albisher HM; Al Saeed WR; Almumtin AT; Allabbad FM; A Shawarby M
BMC Cancer; 2019 Feb; 19(1):170. PubMed ID: 30795755
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of allele-specific PCR and immunohistochemistry for the detection of BRAF V600E mutations in hairy cell leukemia.
Brown NA; Betz BL; Weigelin HC; Elenitoba-Johnson KS; Lim MS; Bailey NG
Am J Clin Pathol; 2015 Jan; 143(1):89-99. PubMed ID: 25511147
[TBL] [Abstract][Full Text] [Related]
30. ddPCR Analysis Reveals BRAF V600E Mutations Are Infrequent in Isolated Pituitary Langerhans Cell Histiocytosis Patients.
Nellan A; Bodlak A; Mirsky DM; Mulcahy Levy J; Garrington TP; Foreman NK; Gilani A; Hayashi M
J Neuropathol Exp Neurol; 2020 Dec; 79(12):1313-1319. PubMed ID: 32930721
[TBL] [Abstract][Full Text] [Related]
31. [Bone and soft tissue Langerhans cell histiocytosis with multinucleated giant cells and BRAF V600E mutation].
Machado I; Columbie A; Nieto Morales G; Forteza-Suarez M; Renó Céspedes JLS; Marhuenda Fluixa A; Llombart-Bosch A
Rev Esp Patol; 2021; 54(2):136-140. PubMed ID: 33726891
[TBL] [Abstract][Full Text] [Related]
32. Major response to vemurafenib in patient with severe cutaneous Langerhans cell histiocytosis harboring BRAF V600E mutation.
Charles J; Beani JC; Fiandrino G; Busser B
J Am Acad Dermatol; 2014 Sep; 71(3):e97-9. PubMed ID: 25128147
[No Abstract] [Full Text] [Related]
33. Progress towards molecular-based management of childhood Langerhans cell histiocytosis.
Héritier S; Emile JF; Hélias-Rodzewicz Z; Donadieu J
Arch Pediatr; 2019 Jul; 26(5):301-307. PubMed ID: 31281037
[TBL] [Abstract][Full Text] [Related]
34. Mutually exclusive extracellular signal-regulated kinase pathway mutations are present in different stages of multi-focal pulmonary Langerhans cell histiocytosis supporting clonal nature of the disease.
Kamionek M; Ahmadi Moghaddam P; Sakhdari A; Kovach AE; Welch M; Meng X; Dresser K; Tomaszewicz K; Cosar EF; Mark EJ; Fraire AE; Hutchinson L
Histopathology; 2016 Sep; 69(3):499-509. PubMed ID: 26915300
[TBL] [Abstract][Full Text] [Related]
35. Langerhans Cell Histiocytosis Associated With Renal Cell Carcinoma Is a Neoplastic Process: Clinicopathologic and Molecular Study of 7 Cases.
Agaimy A; Bonert M; Naqvi A; Wang C; Trpkov K; Dettmar P; Wintzer HO; Stoehr R; Hes O; Williamson SR; Gibson IW; Hartmann A
Am J Surg Pathol; 2020 Dec; 44(12):1658-1665. PubMed ID: 32910018
[TBL] [Abstract][Full Text] [Related]
36. High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis.
Brown NA; Furtado LV; Betz BL; Kiel MJ; Weigelin HC; Lim MS; Elenitoba-Johnson KS
Blood; 2014 Sep; 124(10):1655-8. PubMed ID: 24982505
[TBL] [Abstract][Full Text] [Related]
37. Langerhans cell histiocytosis associated with lymphoma: an incidental finding that is not associated with BRAF or MAP2K1 mutations.
Pina-Oviedo S; Medeiros LJ; Li S; Khoury JD; Patel KP; Alayed K; Cason RC; Bowman CJ; Yin CC
Mod Pathol; 2017 May; 30(5):734-744. PubMed ID: 28084334
[TBL] [Abstract][Full Text] [Related]
38. Langerhans cell histiocytosis associated with classical Hodgkin lymphoma contains BRAF V600E mutation.
Zhang S; Steinhilber J; Fend F
Ann Hematol; 2019 Jan; 98(1):231-233. PubMed ID: 30003317
[No Abstract] [Full Text] [Related]
39. Detection of BRAF V600E mutation in radiological Langerhans cell histiocytosis-associated neurodegenerative disease using droplet digital PCR analysis.
Shimizu S; Sakamoto K; Kudo K; Morimoto A; Shioda Y
Int J Hematol; 2023 Jul; 118(1):119-124. PubMed ID: 37010809
[TBL] [Abstract][Full Text] [Related]
40. Childhood pulmonary Langerhans cell histiocytosis: a comprehensive clinical-histopathological and BRAF
Kambouchner M; Emile JF; Copin MC; Coulomb-Lherminé A; Sabourin JC; Della Valle V; Sileo C; Ducou Le Pointe H; Bégueret H; Galmiche L; Lambilliotte A; Paraf F; Piche M; Piguet C; Rullier A; Secq V; Serre I; Bernaudin JF; Donadieu J
Hum Pathol; 2019 Jul; 89():51-61. PubMed ID: 31054893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]